MYCN and neuroblastoma: Two inhibitors, originally identified as RNA pol I inhibitors, quarfloxin (113) and CX-5461 (114), blocked ribosome synthesis in human MYCN-amplified NB cells, leading to reduction of MYCN protein levels (114).